SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-017047
Filing Date
2024-05-15
Accepted
2024-05-15 16:09:29
Documents
75
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q omer20240331_10q.htm   iXBRL 10-Q 906291
2 EXHIBIT 31.1 ex_618340.htm EX-31.1 12793
3 EXHIBIT 31.2 ex_618341.htm EX-31.2 13463
4 EXHIBIT 32.1 ex_618342.htm EX-32.1 6500
5 EXHIBIT 32.2 ex_618343.htm EX-32.2 6529
  Complete submission text file 0001437749-24-017047.txt   5615598

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA omer-20240331.xsd EX-101.SCH 64972
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE omer-20240331_cal.xml EX-101.CAL 50074
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE omer-20240331_def.xml EX-101.DEF 367946
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE omer-20240331_lab.xml EX-101.LAB 329129
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE omer-20240331_pre.xml EX-101.PRE 398728
79 EXTRACTED XBRL INSTANCE DOCUMENT omer20240331_10q_htm.xml XML 859549
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34475 | Film No.: 24950626
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)